Prognostic significance of blood pressure response to exercise in patients with systolic heart failure

Heart and Vessels

Volumn 27, Issue 1, 2012, Pages 46-52

  Kallistratos, Manolis S ^a   Poulimenos, Leonidas E ^a   Pavlidis, Antonios N ^a   Dritsas, Athanasios ^b   Laoutaris, Ioannis D ^b   Manolis, Athanasios J ^a,c   Cokkinos, Dennis V ^b  

^a IASO GENERAL HOSPITAL   (Greece)

^b ONASSIS CARDIAC SURGERY CENTER   (Greece)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiovascular mortality; Heart failure; Heart transplantation; Low blood pressure

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SPIRONOLACTONE;

ADULT; ARTICLE; BLOOD PRESSURE MONITORING; CARDIOPULMONARY EXERCISE TEST; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; EXERCISE; FEMALE; FOLLOW UP; HAZARD RATIO; HEART LEFT VENTRICLE EJECTION FRACTION; HEART TRANSPLANTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PULSE PRESSURE; RISK ASSESSMENT; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HEART FAILURE; AGED; BLOOD PRESSURE; CHI SQUARE DISTRIBUTION; EXERCISE TEST; GREECE; HEART LEFT VENTRICLE FUNCTION; HEART RATE; HEART STROKE VOLUME; KAPLAN MEIER METHOD; MIDDLE AGED; MULTIVARIATE ANALYSIS; OXYGEN CONSUMPTION; PATHOPHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; RISK FACTOR;

AGED; BLOOD PRESSURE; CHI-SQUARE DISTRIBUTION; EXERCISE; EXERCISE TEST; FEMALE; GREECE; HEART FAILURE, SYSTOLIC; HEART RATE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OXYGEN CONSUMPTION; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT;

EID: 84861178001     PISSN: 09108327     EISSN: 16152573     Source Type: Journal    
DOI: 10.1007/s00380-010-0115-z     Document Type: Article

References (25)

1. Jessup M, Brozena S (2010) Elevated troponin T on discharge predicts poor outcome of decompensated heart failure. Heart Vessels 25:217-222
2. Darne B, Girerd X, Safar M, Cambien F, Guize L (1989) Pulsatile versus steady component of blood pressure: a cross-sectional analysis and a prospective analysis on cardiovascular mortality. Hypertension 13:392-400
3. Franklin SS, Khan SA, Wong ND, Larson MG, Levy D (1999) Is pulse pressure useful in predicting risk for coronary heart disease? The Framingham heart study. Circulation 100:354-360
4. Benetos A, Safar M, Rudnichi A, Smulyan H, Richard JL, Ducimetieere P, Guize L (1997) Pulse pressure: a predictor of long-term cardiovascular mortality in a French male population. Hypertension 30:1410-1415
5. Fang J, Madhavan S, Cohen H, Alderman MH (1995) Measures of blood pressure and myocardial infarction in treated hypertensive patients. J Hypertens 13:413-419
6. Chae CU, Pfeffer MA, Glynn RJ, Mitchell GF, Taylor JO, Hennekens CH (1999) Increased pulse pressure and risk of heart failure in the elderly. JAMA 281:634-639
7. Vaccarino V, Holford TR, Krumholz HM (2000) Pulse pressure and risk for myocardial infarction and heart failure in the elderly. J Am Coll Cardiol 36:130-138
8. Chrysohoou C, Pitsavos C, Barbetseas J, Kotroyiannis I, Brili S, Vasiliadou K, Papadimitriou L, Stefanadis C (2009) Chronic systemic inflammation accompanies impaired ventricular diastolic function, detected by Doppler imaging, in patients with newly diagnosed systolic heart failure (Hellenic Heart Failure Study). Heart Vessels 24:22-26
9. Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfield MJ, Cifkova R, Clément D, Coca A, Dominiczak A, Erdine S, Fagard R, Farsang C, Grassi G, Haller H, Heagerty A, Kjeldsen SE, Kiowski W, Mallion JM, Manolis A, Narkiewicz K, Nilsson P, Olsen MH, Rahn KH, Redon J, Rodicio J, Ruilope L, Schmieder RE, Struijker-Boudier HA, van Zwieten PA, Viigimaa M, Zanchetti A (2009) European Society of Hypertension. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens 27:2121-2158
10. Güder G, Frantz S, Bauersachs J, Allolio B, Wanner C, Koller MT, Ertl G, Angermann CE, Störk S (2009) Reverse epidemiology in systolic and nonsystolic heart failure: cumulative prognostic benefit of classical cardiovascular risk factors. Circ Heart Fail 2:563-571
11. Williams SG, Jackson M, Ng LL, Barker D, Patwala A, Tan LB (2005) Exercise duration and peak systolic blood pressure are predictive of mortality in ambulatory patients with mild-moderate chronic heart failure. Cardiology 104:221-226
12. Lee TT, Chen J, Cohen DJ, Tsao L (2006) The association between blood pressure and mortality in patients with heart failure. Am Heart J 151:76-83
13. Raphael CE, Whinnett ZI, Davies JE, Fontana M, Ferenczi EA, Manisty CH, Mayet J, Francis DP (2009) Quantifying the paradoxical effect of higher systolic blood pressure on mortality in chronic heart failure. Heart 95:56-62
14. Kallistratos MS, Dritsas A, Laoutaris ID, Cokkinos DV (2008) Incremental value of N-terminal pro-brain natriuretic peptide over left ventricle ejection fraction and aerobic capacity for estimating prognosis in heart failure patients. J Heart Lung Transplant 27:1251-1256
15. Kallistratos MS, Dritsas A, Laoutaris ID, Cokkinos DV (2007) N-terminal prohormone brain natriuretic peptide as a marker for detecting low functional class patients and candidates for cardiac transplantation: linear correlation with exercise tolerance. J Heart Lung Transplant 26:516-521
16. Mancini DM, Eisen H, Kussmaul W, Mull R, Edmunds LH Jr, Wilson JR (1991) Value of peak exercise consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation 83:778-786
17. Riley M, Northridge DB, Henderson E, Stanford CF, Nichols DP, Dargie HJ (1992) The use of an exponential protocol for bicycle and treadmill exercise testing in patients with chronic cardiac failure. Eur Heart J 13:1363-1367
18. Wu A, Smith A, Wieczorek S, Mather J, Duncan B, White C, McGill C (2003) Biological variation for N-terminal Pro and B-type natriuretic peptides and implications for therapeutic monitoring of patients with congestive heart failure. Am J Cardiol 92:628-631
19. Domanski MJ, Mitchell GF, Norman JE, Exner DV, Pitt B, Pfeffer MA (1999) Independent prognostic information provided by sphygmomanometrically determined pulse pressure and mean arterial pressure in patients with left ventricular dysfunction. J Am Coll Cardiol 33:951-958
20. Voors A, Petrie C, Petrie M (2005) Low pulse pressure is independently related to elevated natriuretic peptides and increased mortality in advanced chronic heart failure. Eur Heart J 26:1759-1764
21. Kostis JB, Davis BR, Cutler J, Grimm RH Jr, Berge KG, Cohen JD, Lacy CR, Perry HM Jr, Blaufox MD, Wassertheil-Smoller S, Black HR, Schron E, Berkson DM, Curb JD, Smith WM, McDonald R, Applegate WB (1997) Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension. SHEP Cooperative Research Group. JAMA 278:212-216
22. Weber MA (1987) Cardiovascular outcomes of treating high blood pressure. Am Heart J 114:964-971
23. Messerli FH, Mancia G, Conti CR, Hewkin AC, Kupfer S, Champion A, Kolloch R, Benetos A, Pepine CJ (2006) Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous? Ann Intern Med 144:884-893
24. Anand IS, Tam SW, Rector TS, Taylor AL, Sabolinski ML, Archambault WT, Adams KF, Olukotun AY, Worcel M, Cohn JN (2007) Influence of blood pressure on the effectiveness of a fixeddose combination of isosorbide dinitrate and hydralazine in the African-American Heart Failure Trial. J Am Coll Cardiol 49:32-39
25. Jourdain P, Jondeau G, Funck F, Gueffet P, Le Helloco A, Donal E, Aupetit JF, Aumont MC, Galinier M, Eicher JC, Cohen-Solal A, Juillière Y (2007) Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study. J Am Coll Cardiol 49:1733-1739